The case concerned a medical trial of Akero’s solely product, a drug candidate aimed toward treating a liver illness. It is the second time U.S. District Decide Yvonne Gonzalez Rogers has ordered dismissal.
Trending
- High Wycombe man who shot PC with crossbow jailed
- Thousands of Grok chats are now searchable on Google
- Why are food prices rising so fast?
- Xbox Ally handhelds will be available October 16, but we still don’t know the price
- How the Trump right helps their young thinkers — and why liberals don’t
- ASUS ProArt PA32UCDM review: At last, an OLED monitor for creative pros
- Met police’s facial recognition plans fall foul of European law, says watchdog | Police
- Onimusha Way of the Sword Hands-On: Back to the Demon-Killing Samurai Grind
Latham Wins Dismissal of Securities Action Involving Liver Disease Drug Developer
